State to get 23,000 doses of ‘Covishield’ in 2 days

0
35

NT NETWORK

Panaji

The health services directorate on Tuesday said  the first batch of 23,000 doses of COVID-19 vaccine ‘Covishield’ will be delivered to Goa in the next two days.

A senior officer at the DHS told ‘The Navhind Times’ that an official communiqué has been received by the department from the Union ministry of health and family welfare that said 23,000 doses of Covishield vaccine will be dispatched for Goa from the Pune-based Serum Institute of India.

“Today, we have received a message from the Union health ministry that we will be provided with the vaccine doses within one or two days from the SII. All preparations and arrangements have been made by us. The DHS is all set to launch the first phase of the COVID-19 vaccination programme in Goa on January 16,” the senior officer said.

The first batch of doses  has been allocated to the state for inoculation of military personnel, central government employees and state healthcare workers.

“With 23,000 doses of the vaccine, we will be cover around 11,500 beneficiaries as they will receive two doses of the vaccine. There will be a gap of 28 days between both the doses. And as and when we get more supply of the doses, more people can be covered,” the officer said.

It is pertinent to note that the state health department has already received over one lakh auto-disable syringes from the MoHFW that will be used during the first phase of the COVID-19 vaccination drive.

Meanwhile, the state unit of the Indian Medical Association has announced that it will actively take part in the COVID vaccination programme.

The IMA at national level has requested all its 3.5 lakh members in 1800 local branches all over India to voluntarily come out to get vaccinated first so as to show to the world that these vaccines are safe and efficacious.

“We request all esteemed members of our branches of the IMA  to ensure that all our healthcare team is getting the priority vaccination,”  said the statement issued by the IMA.

The IMA has said that it rightfully stands firm as the natural and professional stakeholder in this achievement not only in the development of the vaccine but also in delivering the vaccine.